Jessica C Ling

Title: Jessica C Ling: Innovator in Synthetic Biology and Cancer Diagnostics

Introduction

Jessica C Ling is a prominent inventor based in Bensalem, PA (US). She has made significant contributions to the fields of synthetic biology and cancer diagnostics. With a total of 3 patents to her name, her work has the potential to impact public health and medical research.

Latest Patents

One of her latest patents is focused on synthetic virus-like particles with heterologous epitopes. This invention comprises a series of synthetic virus-like particles that are useful in characterizing human papillomavirus (HPV) infections. It also provides a method for vaccinating individuals against HPV 6 and HPV 11 infections, along with assays employing these synthetic particles. Another notable patent involves mutations in the human MLH1 and MSH2 genes, which are crucial for diagnosing colorectal cancer. This patent provides methods for using these variant genes to diagnose hereditary non-polyposis colorectal cancer (HNPCC) and assess a patient's susceptibility to developing this condition. Additionally, it includes experimental models for HNPCC that utilize these variant genes.

Career Highlights

Jessica has worked with reputable companies such as Merck & Company, Inc. and Diadexus, Inc. Her experience in these organizations has allowed her to develop innovative solutions in her field.

Collaborations

Throughout her career, Jessica has collaborated with notable colleagues, including Kathrin Ute Jansen and Steven W Ludmerer. These partnerships have contributed to her success and the advancement of her research.

Conclusion

Jessica C Ling is a trailblazer in the realm of synthetic biology and cancer diagnostics. Her innovative patents and collaborations highlight her commitment to improving healthcare outcomes. Her work continues to inspire future advancements in medical research and technology.